“…There are 13 published reports of studies using a microtransplantation approach for persons with AML only (Table). A randomized clinical trial of elderly individuals (>65 years of age) with AML compared chemotherapy with (n = 28) or without (n = 30) microtransplantation . Participants receiving a microtransplant had a higher rate of histologic complete remission (80% [95% CI, 65%-95%] vs 43% [95% CI, 23%-63%]; P = .006), 2-year leukemia-free survival (39% [95% CI, 20%-58%] vs 10% [95% CI, 0%-20%]; P = .01) and 2-year survival (39% [95% CI, 21%-57%] vs 10% [95% CI, 0%-22%]; P = .006).…”